Mixed modality treatment planning of accelerated partial breast irradiation: to improve complex dosimetry cases

por El Nemr, Mohamed, Heymann, Steve, Verstraet, Rodolfe, Biron, Bruno, Azoury, Fares, Marsiglia, Hugo, Bourgier, Céline
Publicado em 2011

Assessment of Serum CoQ10 Levels and other Antioxidant Markers in Breast Cancer

por El-Attar, Eman, Kamel, Amel, Karmouty, Ahmed, Wehida, Nadine, Nassra, Rasha, El Nemr, Mohamed, Kandil, Noha Said
Publicado no Asian Pac J Cancer Prev (2020)

Evaluation of Apoptotic Marker Bcl2, CD4+, Human Hepatocyte Growth Factor and Metalloproteinase-9 as Tumor Markers for Patients with Hepatocellular Carcinoma

por Youness, Eman R., El Nemr, Mohamed, Oraby, F. S., Ahmed, Nadia M., Moghni, Mohamed A., Aly, Hanan F., Ahmed, Hanaa H.
Publicado em 2013

Higher toxicity with 42 Gy in 10 fractions as a total dose for 3D-conformal accelerated partial breast irradiation: results from a dose escalation phase II trial

por Bourgier, Celine, Acevedo-Henao, Catalina, Dunant, Ariane, Rossier, Christine, Levy, Antonin, El Nemr, Mohamed, Dumas, Isabelle, Delaloge, Suzette, Mathieu, Marie-Christine, Garbay, Jean-Remi, Taghian, Alphonse, Marsiglia, Hugo
Publicado em 2012